Associate Professor David Ross
|Flinders Medical Centre (FMC)|
Royal Adelaide Hospital (RAH)
|Practice Responsibilities:||Haematology molecular diagnostics, Lead clinician for myeloproliferative neoplasms|
A/Prof Ross trained in clinical and laboratory haematology at the Royal Adelaide Hospital and Institute of Medical & Veterinary Science (now SA Pathology). In 2009, he was awarded a PhD for his thesis on the subject of minimal residual disease in chronic myeloid leukaemia (CML). He has formal scope of practice in genetic testing pertinent to haematology. He is an academic haematologist with clinical and research interests in all aspects of myeloid malignancy, from diagnosis to treatment, with a primary focus on CML and myeloproliferative neoplasms (MPN).
He is head of the Haematology Clinical Trials Unit in RAH, and principal investigator in trials in CML and MPN. He was elected chair of the CML/MPN Working Party of the Australasian Leukaemia and Lymphoma Group in 2017. Dr Ross is Director of the South Australian Cancer Research Biobank. He is a Senior Visiting Research Fellow in the SA Health and Medical Research Institute, and Adjunct Associate Professor in the Centre for Cancer Biology (a joint initiative of SA Pathology and UniSA). He was appointed as an examiner for the Royal College of Pathologists of Australasia in 2015 and as editor of the journal, Leukemia Research, in 2017.